Premier Alternatives

Myosin Therapeutics

Jupiter, FL · Founded 2020 · Privately Held (backing)

Operator of a biopharmaceutical company intended to treat significant unmet medical needs. Myosin Therapeutics is based in Jupiter, FL and was founded in 2020. It is valued at about $30 million as of Oct 2026, set by institutional fund marks. It has raised $6.9 million across 1 recorded round; the latest was a $3 million seed round in Dec 2022.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its seed round
Feb 2025
Total raised
$6.9M
Last round
Seed Round
Dec 2022

Myosin Therapeutics key facts

as of Oct 2026
  • Operator of a biopharmaceutical company intended to treat significant unmet medical needs.
  • Myosin Therapeutics is valued at approximately $30.0M as of Oct 2026, per PrivateMarketView’s mark.
  • It has raised $6.9M across 1 recorded rounds; the latest was Seed Round ($3.0M) in Dec 2022.
  • Notable investors include National Institutes of Health, Endless Frontier Labs, Florida Opportunity Fund, Mayo Clinic Ventures, Deepwork Capital — 11 tracked in total.
  • 1 institutional filer reports fund marks on Myosin Therapeutics across 2 filings.
  • Myosin Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently Mar 2023 ($3.0M sold to 4 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$30.0M

Nothing comparable since the round — shown at its seed round, Feb 2025 ($30.0M post-money).

set by institutional fund marksas of Oct 2026question about this number?
Free account
More of Myosin Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Myosin Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Institutional fund marks on Myosin Therapeutics

1 filers · latest May 2026

1 SEC-registered fund reported 2 fair-value marks on Myosin Therapeutics between May 2026 and May 2026. Filer-level marks and implied $/share are available to Pro members.

Unlock 2 fund marks

Membership and data by Private Market View

Every name the funds mark, next to where it trades →

Myosin Therapeutics funding rounds

1 rounds
Dec 2022Seed Round$3.0MSEC filing▮
Full funding history →

Myosin Therapeutics valuation

Myosin Therapeutics is valued at approximately $30 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its seed round in Feb 2025, at a $30 million post-money valuation.

How much has Myosin Therapeutics raised?

Myosin Therapeutics has raised $6.9 million in total; 1 of its rounds is on record. The largest on record was a $3 million seed round in Dec 2022.

Myosin Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Mar 2023 ($3 million sold to 4 investors).

Institutional holders and vehicles

1 SEC-registered fund reported 2 fair-value marks on Myosin Therapeutics for May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

Myosin Therapeutics investors

11 investors are on record for Myosin Therapeutics, including National Institutes of Health, Endless Frontier Labs, Florida Opportunity Fund and Mayo Clinic Ventures. The seed round in Dec 2022 drew 4 investors.

About Myosin Therapeutics

Operator of a biopharmaceutical company intended to treat significant unmet medical needs. The company focuses on developing novel medications targeting cellular motor proteins and specializes in molecular machines that convert energy into mechanical work inside cells, enabling doctors to treat areas of disease through the development of novel pharmacotherapies.

Sector
Healthcare
HQ
Jupiter, FL, United States
Founded
2020
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.